Apremilast
Back to searchMolecule Structure
Scientific Name
Apremilast
Description of the Drug
Apremilast is a non-steroidal medication used for the treatment of inflammatory conditions such as psoriasis and psoriatic arthritis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB05676
http://www.drugbank.ca/drugs/DB05676
Brand Name(s)
Otezla
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Alkem Laboratories Ltd, Amneal Eu Ltd, Unichem Laboratories Ltd, Zydus Pharmaceuticals Usa Inc, Amgen Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Phosphodiesterase 4 | PROTEIN FAMILY | INHIBITOR | CHEMBL2093863 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL302992 | |
| DrugBank | DB05676 | |
| PubChem: Thomson Pharma | 16663888 | |
| PubChem | 11561674 | |
| LINCS | LSM-45894 | |
| Nikkaji | J3.327.552H | |
| PDBe | A9L | |
| BindingDB | 50248919 | |
| DrugCentral | 4829 | |
| Brenda | 12137 | |
| ChemicalBook | CB12563430 | |
| Guide to Pharmacology | 7372 | |
| rxnorm | APREMILAST | OTEZLA |
| PubChem: Drugs of the Future | 50086920 | |
| ChEBI | 78540 | |
| ZINC | ZINC000030691736 |
